About MEDOVENT Exit

Development of innovative, bioabsorbable products with a focus on medical applications.

Info & Contact

Address

In portfolio

11. Oct 2006 – 31. Oct 2018

Sector

 

Kay G. Balster

Principal / Authorized signatory
Exit